What We're Reading: Page 243
Industry reads hand-picked by our editors
Feb 12, 2019
-
STAT
How can we make the J.P. Morgan Healthcare Conference better?
-
Nature
An audience with Hal Barron
-
Kaiser Health News
A 'Fountain Of Youth' Pill? Sure, If You're A Mouse.
-
The Wall Street Journal
FDA Challenges Supplement Makers' Marketing Claims
Feb 11, 2019
-
Nature
Stock price effects of breakthrough therapy designation
-
Bloomberg
China's potential HIV contamination revives drug safety fears
-
The Wall Street Journal
24-Hour Flu Pill May Not Be Miracle Drug Doctors Thought
-
Nikkei Asian Review
Biotech startup turns palm waste into high-value chemicals
-
The Washington Post
Unvaccinated teens are fact-checking their parents — and trying to get shots on their own
Feb 08, 2019
-
Kaiser Health News
Trump Administration Salutes Parade Of Generic Drug Approvals, But Hundreds Aren’t For Sale
-
Xconomy
New CRISPR Fight: Old Friends Intellia, Caribou in License Dispute
-
The Philadelphia Inquirer
Hotel, pharma lobbyists win Philly City Council vote against drug rep law
-
Bloomberg
Biotech Alector Drops as IPOs Restart After U.S. Shutdown
-
The Wall Street Journal
Big Pharma’s Big Cancer Hope Is Fizzling
Feb 07, 2019
-
Reuters
Novartis CEO lauds Trump administration plan to overhaul rebates
-
USA Today
Trump's border wall won't solve addiction crisis — but finally targeting big pharma can
-
Boston Business Journal
Here are the largest Series A rounds in Mass. biotech
-
STAT
Cancer treatment at home is closer to happening than you think
Feb 06, 2019
-
Politico
Democrats bat away Trump's olive branch on drug pricing
-
The Guardian
Self-regulation by the pharmaceutical industry isn't working, say experts
-
BioCentury
Pain Therapeutics chides FDA for 'shambolic' abuse-deterrent regulations
-
Financial Times
Chinese biotech feels chill in harsh winter for venture capital
Feb 05, 2019
-
Undark
Policing big pharma's influence over doctors' treatment guidelines
-
Boston Business Journal
$100 per square foot for biotech lab space? It could soon be coming to Cambridge
-
Medical Marketing & Media
How pharma is tightening up data privacy and security
-
The Hill
Ocasio-Cortez fires back at critic who called her drug industry knowledge 'inadequate'
Feb 04, 2019
-
CNBC
Bristol-Myers Squibb shares pop on report Starboard Value has taken a stake in the drugmaker
-
Vantage
The list of shame no biopharma wants to join
-
Kaiser Health News
Winners And Losers Under Bold Trump Plan To Slash Drug Rebate Deals
-
STAT
As cystic fibrosis drugs deliver new hope, progress isn't reaching everyone
Previous
